Anti‐tumor activity of a blocked ricin immunotoxin with specificity against the cluster‐5A antigen associated with human small‐cell lung cancer

International Journal of Cancer

Volumn 54, Issue 6, 1993, Pages 1028-1035

  Zangemeister‐Wittke, Uwe ^a   Collinson, Albert R ^c   Fisch, Igor ^b   Jones, Robert M L ^b   Waibel, Robert ^a   Lehman, Hans‐Peter ^a   Stahel, Rolf A ^a  

^a University Hospitals   (United Kingdom)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Genetics Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GALLIUM 67; IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SEN31; RICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, SMALL CELL; FEMALE; HUMAN; IMMUNOTOXINS; LUNG NEOPLASMS; MICE; MICE, INBRED ICR; MICE, NUDE; RICIN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0027210093     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910540628     Document Type: Article

References (28)

1. Results of the central data analysis
2. An overview of therapy with immunotoxins containing ricin or its A chain
3. Blocked and not blocked whole‐ricin‐antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude mice
4. Potentia‐tion of a weakly active ricin A‐chain immunotoxin recognizing the neural cell‐adhesion molecule
5. Cytotoxic properties of a ricin A‐chain immunotoxin recognising the cluster‐5A antigen associated with human small‐cell kins cancer
6. The specific cytotoxicity of immunoconjugates containing blocked ricin is dependent on the residual binding capacity of blocked ricin: evidence that the membrane‐binding and A‐chain‐translocation activities of ricin cannot be separated
7. Serotherapy of B‐cell neoplasms with anti‐B4‐blocked ricin: a phase‐I trial of daily bolus infusion
8. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure
9. Application of stepwise regression to non‐linear estimation
10. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use
11. The galac‐tose‐binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of elycopeptides containing triantennary N‐linked oligo‐saccharides
12. Expression of the small‐cell‐lung‐carcinoma antigens of clus‐ter‐5 and cluster‐5A in primary lung tumours
13. Normalization in the fitting of data by iterative methods
14. A novel derivative of the chelon desferriox‐amine for site‐specific conjugation to antibodies
15. Anti‐MY9‐blocked‐ricin: an immunotoxin for selective targeting of acute‐myeloid‐leukemia cells
16. Immunolocalisation and imaging of small‐cell‐cancer xenocrafts by the IgG2a monoclonal antibody SWA11
17. Antigens of lung cancer: results of the second international workshop on lung‐cancer antigens
18. Longevity in small‐cell lung cancer. A report to the lung‐cancer subcommittee of the United Kingdom coordinating committee for cancer research
19. Blockade of the galactose‐binding sites of ricin by its linkage to antibody. Specific cytotoxic etfects of the conjugates. Europ
20. Determination of equilibrium binding parameters of monoclonal antibodies specific for cell‐surface antigens
21. Tumor‐associated membrane sialoglycoprotein on human small‐cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20
22. Monoclonal antibodies defining the cluster‐5A small‐cell‐lung‐carcinoma antigen
23. Selective cytotoxic effect of a ricin A‐chain immunotoxin made with the monoclonal antibody SWAl 1 recognising a human small‐cell‐lung‐cancer antigen
24. Cytotoxic activity of ricin A‐chain immunotoxins recognising cluster‐1, ‐w4 and ‐5A antigens associated with human small‐cell lung cancer
25. Blocked and non‐blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A‐chain immunotoxin potentiated with ricin B chain or with ricin B‐chain immunotoxin
26. Molecular and biological properties of an abrin A‐chain immunotoxin designed for therapy of human small‐cell lung cancer
27. 50) and instructions in their use
28. Action of a CD24‐specific deglycosylated ricin A‐chain immunotoxin in conventional and novel models of small‐cell lung‐cancer xenograft